Atossa Therapeutics Inc
(FRA:YAG2)
€
1.22
-0.01 (-0.81%)
Market Cap: 169.90 Mil
Enterprise Value: 98.75 Mil
PE Ratio: 0
PB Ratio: 2.37
GF Score: 42/100 Atossa Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Sep 28, 2023 / 01:10PM GMT
Release Date Price:
€0.7225
(+3.14%)
Carvey Leung
Cantor Fitzgerald - Analyst
Good morning, everyone. My name is Carvey, a research associate here at Cantor. Thank you for joining us for a fireside chat. We have Atosis (sic - Atossa). Steve, can you introduce yourself?
Steven Quay
Atossa Therapeutics, Inc. - Chairman and CEO
Yeah. So I am Steven Quay. I'm the CEO and Founder of Atossa Therapeutics.
Questions & Answers
Carvey Leung
Cantor Fitzgerald - Analyst
Awesome. To start, what is your company's strategic vision? Where is the company now, and where do you want it to be in three to five years?
Steven Quay
Atossa Therapeutics, Inc. - Chairman and CEO
So Atossa, Princess Atossa, was the first woman in recorded history with breast cancer, 454 B.C. She was the wife of Darius the Great. And her cancer was treated by cauterizing it; didn't do very well. But we're dedicated from the very beginning with treating breast cancer and breast conditions.
So we are looking at the entire spectrum
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot